Valion Bio, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINES-3Valion Bio, Inc.TIVC2d

   Valion Bio files S-3 form

   • Filed on 2026-10-16
   • Registers 3,954,381 shares of common stock
   • Includes shares from Series B and C preferred stock conversions
2. ROUTINEDEF 14AValion Bio, Inc.TIVC2d

   Valion Bio to hold special meeting on Nov 12

   • Special meeting on Nov 12, 2026
   • Proposals to amend certificate of incorporation
   • Increase in shares authorized under 2021 Plan by 272,000
3. ROUTINE8-KValion Bio, Inc.TIVC4d

   Valion Bio announces BioScan-NMR evaluation

   • Completed feasibility evaluation of LarmorBio's BioScan-NMR platform
   • Press release filed as Exhibit 99.1
   • Date: October 15, 2026
4. ROUTINE8-KValion Bio, Inc.TIVC5d

   Valion Bio, Inc. announces Velocity Bioworks expansion.

   • October 14, 2026 press release
   • Velocity Bioworks offers GMP drug substance manufacturing
   • Section 232 tariffs affect imported pharmaceuticals
5. ROUTINES-3Valion Bio, Inc.TIVCOct 8

   Valion Bio files S-3 for $100M securities

   • Filed Form S-3 on 2026-10-08
   • Up to $100,000,000 in securities including common stock, debt, warrants
   • Includes $5,000,000 under At The Market Offering with Rodman & Renshaw LLC
6. ROUTINE8-KValion Bio, Inc.TIVCOct 8

   Valion Bio, Inc. raises $50,000

   • Entered into a letter agreement with 3i, LP on 10/7/2026
   • Issued 50 Series B Preferred Shares
   • Issued warrants for 1,539 common shares
7. ROUTINE8-KValion Bio, Inc.TIVCOct 6

   Valion Bio names Thomas Jensen as board chair

   • New board chair Thomas Jensen has 20+ years of biotech experience
   • Entolimod has FDA Fast Track and Orphan Drug designations
   • Valion received $35.6M in government funding for Entolimod
8. ROUTINEPRE 14AValion Bio, Inc.TIVCOct 2

   Valion Bio, Inc. announces proxy meeting

   • Filed on 2026-10-02
   • Special Meeting on [____], 2026
   • Proposals for reverse stock split and equity plan amendment
9. ROUTINE8-KValion Bio, Inc.TIVCOct 1

   Current report

10. ROUTINE4Valion Bio, Inc.TIVCSep 24

    2 insider filings

    Dean Zikria, insider filing for TIVC

    Show all 2

    • 4Insider filing for TIVCSep 24
    • 4Insider filing for TIVCSep 24

    Dean Zikria, reporting

11. ROUTINE8-KValion Bio, Inc.TIVCSep 23

    Current report

12. ROUTINE3Valion Bio, Inc.TIVCSep 17

    2 insider filings

    Thomas Jensen, new insider at TIVC

    Show all 2

    • 3New insider at TIVCSep 17
    • 3New insider at TIVCSep 17

    Thomas Jensen, reporting

13. ROUTINESCHEDULE 13G/AValion Bio, Inc.TIVCSep 4

    Ownership stake disclosure by 3i, LP (amended)

    3i, LP, filed by

14. NOTABLESCHEDULE 13D/AValion Bio, Inc.TIVCSep 4

    Ownership stake disclosure by 3i, LP (amended)

    3i, LP, filed by

15. NOTABLESCHEDULE 13D/AValion Bio, Inc.TIVCSep 2

    Ownership stake disclosure by 3i, LP (amended)

    3i, LP, filed by

16. ROUTINE8-KValion Bio, Inc.TIVCSep 1

    Current report

17. NOTABLESCHEDULE 13D/AValion Bio, Inc.TIVCAug 27

    Ownership stake disclosure by 3i, LP (amended)

    3i, LP, filed by

18. ROUTINE8-KValion Bio, Inc.TIVCAug 27

    Current report

19. NOTABLESCHEDULE 13D/AValion Bio, Inc.TIVCAug 24

    Ownership stake disclosure by 3i, LP (amended)

    3i, LP, filed by

20. ROUTINERWValion Bio, Inc.TIVCAug 24

    RW filing

21. ROUTINE8-K/AValion Bio, Inc.TIVCAug 20

    Current report (amended)

22. NOTABLESCHEDULE 13D/AValion Bio, Inc.TIVCAug 19

    Ownership stake disclosure by 3i, LP (amended)

    3i, LP, filed by

23. ROUTINE8-KValion Bio, Inc.TIVCAug 17

    Current report

24. NOTABLESCHEDULE 13D/AValion Bio, Inc.TIVCAug 14

    Ownership stake disclosure by 3i, LP (amended)

    3i, LP, filed by

25. NOTABLE10-QValion Bio, Inc.TIVCAug 14

    Quarterly report

26. ROUTINEEFFECTValion Bio, Inc.TIVCAug 13

    Registration declared effective

27. NOTABLESCHEDULE 13D/AValion Bio, Inc.TIVCAug 11

    Ownership stake disclosure by 3i, LP (amended)

    3i, LP, filed by

28. ROUTINE8-KValion Bio, Inc.TIVCAug 6

    Current report

29. NOTABLESCHEDULE 13DValion Bio, Inc.TIVCAug 3

    Ownership stake disclosure by 3i, LP

    3i, LP, filed by

30. ROUTINEDEF 14AValion Bio, Inc.TIVCJul 17

    Proxy statement

31. NOTABLES-1Valion Bio, Inc.TIVCJul 17

    Securities offering

32. ROUTINESCHEDULE 13GValion Bio, Inc.TIVCJul 17

    Ownership stake disclosure by Murchinson Ltd.

    Murchinson Ltd., filed by

33. ROUTINE8-KValion Bio, Inc.TIVCJul 14

    Current report

34. ROUTINEPRE 14AValion Bio, Inc.TIVCJul 7

    Preliminary proxy statement

35. ROUTINE4Valion Bio, Inc.TIVCJun 18

    Lisa G Wolf, insider filing for TIVC

    Lisa G Wolf, reporting

36. ROUTINE8-KValion Bio, Inc.TIVCJun 18

    Current report

37. ROUTINES-8Valion Bio, Inc.TIVCJun 5

    Employee stock plan registration

38. ROUTINES-8Valion Bio, Inc.TIVCJun 5

    Employee stock plan registration

39. ROUTINE8-KValion Bio, Inc.TIVCJun 3

    Current report

40. ROUTINE4Valion Bio, Inc.TIVCMay 20

    Michael K Handley, insider filing for TIVC

    Michael K Handley, reporting

41. NOTABLE10-QValion Bio, Inc.TIVCMay 14

    Quarterly report

42. ROUTINE8-KValion Bio, Inc.TIVCMay 14

    Current report

43. ROUTINESCHEDULE 13G/AValion Bio, Inc.TIVCMay 8

    Ownership stake disclosure by 3i, LP (amended)

    3i, LP, filed by

44. ROUTINE4Valion Bio, Inc.TIVCMay 4

    2 insider filings

    Melinda Lackey, insider filing for TIVC

    Show all 2

    • 4Insider filing for TIVCMay 4
    • 3New insider at TIVCMay 4

    Melinda Lackey, reporting

45. ROUTINE8-KValion Bio, Inc.TIVCMay 4

    Current report

46. ROUTINEARSValion Bio, Inc.TIVCApr 30

    Annual report to shareholders

47. ROUTINEDEF 14AValion Bio, Inc.TIVCApr 30

    Proxy statement

Older filings on EDGAR